Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Mouse Cancer Genome Unveils Genetic Errors in Human Cancers

March 24, 2011 11:57 am | News | Comments

Scientists who pioneered sequencing the genomes of cancer patients to find novel genetic changes at the root of the disease now have turned their attention to a laboratory workhorse—a mouse.


First Look at Full Multiple Myeloma Genome

March 24, 2011 11:54 am | News | Comments

Scientists have unveiled the most comprehensive picture to date of the full genetic blueprint of multiple myeloma, a form of blood cancer. A study of the genomes from 38 cancer samples has yielded new and unexpected insights.


New Pill Prevents Type 2 Diabetes

March 24, 2011 11:50 am | News | Comments

A pill taken once a day in the morning prevented type 2 diabetes in more than 70 percent of individuals whose obesity, ethnicity and other markers put them at highest risk for the disease


Two New Targets for Melanoma Therapies

March 24, 2011 11:48 am | News | Comments

The latest clues suggesting potential new ways to treat melanoma come from an unlikely source: fish. Zebrafish don't get sunburns, but they can get skin cancer – at least those fish that have been engineered to model the often deadly human cancer.


Almac And Exco Working Together

March 24, 2011 11:41 am | News | Comments

The Almac Group and Exco InTouch announced that Almac’s Clinical Technologies business unit has formed a patient management alliance with Exco InTouch, an innovative firm specializing in patient recruitment, retention, compliance and ePRO services.


ProImmune Receives GLP Certification

March 24, 2011 11:37 am | News | Comments

ProImmune Ltd. announced that it has been accepted into the UK GLP compliance monitoring program by the Medicines & Healthcare products Regulatory Agency formally confirming ProImmune’s compliance with GLP.


Peptide Workstation

March 24, 2011 7:58 am | Product Releases | Comments

Biotage, a supplier of tools and technology for medicinal, analytical, and peptide chemistry, introduced the Biotage Initiator Peptide Workstation for manual microwave-assisted peptide synthesis.


qPCR Assays

March 24, 2011 7:56 am | Product Releases | Comments

Integrated DNA Technologies (IDT) now offers PrimeTime Pre-designed qPCR Assays which are guaranteed to work for human, mouse, and rat transcriptomes.


Diaphragm Pumps

March 24, 2011 7:52 am | Drug Discovery & Development | Product Releases | Comments

KNF LABOPORT Filtration Series diaphragm pumps provide ideal solutions for a wide range of applications in the lab, including flask filtration, vacuum blotting, vacuum manifold, and vacuum desiccation.


RFID-Enabled Refrigerator

March 24, 2011 7:48 am | Product Releases | Comments

Terso Solutions, Inc. has expanded its line of RFID-enabled enclosures with the addition of a refrigerator that is well-suited for hospital and laboratory inventory management.


Gentel-VARI Awarded Glycosylation Patent

March 24, 2011 7:45 am | News | Comments

Gentel Biosciences and Van Andel Research Institute jointly announced the granting of U.S. Patent 7,838,634 for a new method to profile changes in the glycosylation of proteins captured on the surface of an antibody array slide.


PerkinElmer to Buy CambridgeSoft

March 24, 2011 7:42 am | News | Comments

PerkinElmer, Inc., a global company focused on health and safety, announced that it has signed a definitive agreement to acquire CambridgeSoft Corporation, and has completed the purchase of ArtusLabs, Inc.


Bird Embryo Provides Insight Into Cancer and Wound Healing

March 24, 2011 7:40 am | News | Comments

Avian embryos could join the list of model organisms used to study a specific type of cell migration called epiboly, thanks to the results of a study published this month in the journal Developmental Dynamics.


Telomerase Inhibitor Also A Key Tumor Suppressor

March 24, 2011 7:36 am | News | Comments

It's been nearly 10 years since PinX1, the first potent endogenous protein shown to inhibit telomerase in mammals, was discovered. Now scientists have discovered a vitally important new function for this telomerase inhibitor.


Prosensa Releases PRO051 Results

March 24, 2011 7:25 am | News | Comments

Prosensa, a biopharmaceutical company focusing on RNA modulating therapeutics, announces the publication of results from a phase 1/2 and 12-week extension study of its lead product, PRO051 for the treatment of Duchenne Muscular Dystrophy.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.